Risk communication and specific medicines for women

Abstract

In this chapter we review the detailed issues, questions and skills of risk communication in practice, relevant to medicines for all patients and then focus on challenges of communication with regard to a small selection of medicines for women: anticonvulsants in pregnancy, oral contraceptives, HPV vaccination and Hormone Replacement Therapy (HRT).